ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...

The Global Intraocular Lens Market valued at US $3.9 billion in 2021 and is set to witness a growth rate of ~5-6% in the next 5 years. The global growth in cataract procedures driven by an aging ...

Alcon also has a suite of advanced-technology intraocular lenses, or ATIOLs, that go beyond correcting vision issues at one distance. Although today’s global ATIOL market penetration rate by ...

Alcon ALC recently received Food and Drug Administration (“FDA”) approval for its TRYPTYR (acoltremon ophthalmic solution) 0.003%. TRYPTYR is indicated for the treatment of the signs and symptoms of ...

Breakthrough instruments like optical coherence tomography (OCT) and affordable intraocular lenses (IOLs) broaden the availability of cutting-edge ophthalmic care, enhancing early detection and ...

According to Focus Report's latest research report, the global ophthalmic implants market is growing at a CAGR of 7.48% ...

Alcon, Inc. ALC delivered first-quarter 2025 core earnings per share (EPS) of 73 cents, down 6.4% from the year-ago quarter’s ...

Presbyopia-correcting intraocular lenses (PC-IOLs) offer the potential for spectacle ... Thirty-one patients (62 total) received either Symfony OptiBlue (J&J Vision) or Clareon Vivity (Alcon).

Secondary IOL implantation improved visual acuity over time across several types of techniques, according to a speaker.At ...